ProQR Therapeutics held annual shareholder meeting in Amsterdam
PRQR•Annual general meeting resolutions
ProQR Therapeutics held its annual general meeting on June 2, 2026.
- Shareholders adopted the 2025 annual accounts, including the appropriation of the net result.
- Shareholders granted discharge from liability to board members for their duties during 2025.
- Investors appointed Dr. Lykke Hinsch Gylvin as a non-executive board member for a four-year term.
- Other resolutions passed included appointing KPMG as 2027 auditor, increasing authorized capital, authorizing share issuance, and authorizing share buybacks.
